Rebecca Fitzgerald, Lucy Hart, and Sadie Harris - these are just some of the aliases used by Cookes, the jailed fraudster ...

Huntington explained the cows have their own legacy within the records of the camp. In a report filed by superintendent Willard Turner, the cows were a source of pride for the entire prison, along ...

Joe Locke has landed his first ever West End role, starring in Clarkston, a play about two men who form a deep bond while working at a warehouse in a rural American town. The 21-year-old actor is ...

Industrial sectors are on the cusp of major changes, driven by new tech. It’s not just about doing things faster; it’s about ...

Just two years after losing their first daughter, a San Angelo family has lost their second daughter to Huntington's disease.

In the complex world of neuroscience, Huntington's disease remains a cruel mystery. It slowly strips away a person’s ability ...

Scott Porter’s wife Kelsey Mayfield Porter learned in 2014 that she was positive for the Huntington’s disease gene. The actor opened up to PEOPLE and praised her ability to not let the ...

Huntington's disease has long defied attempts to rescue suffering neurons. A new study in Cell Reports shows that transplanting healthy human glial progenitor cells into the brains of adult animal ...

NUZ-001 and its active metabolite NUZ-001 Sulfone demonstrated significant neuroprotective effects in a zebrafish model of Huntington's disease Treatment prevented hallmark developmental and ...

Huntington's disease articles from across Nature Portfolio Huntington's disease is a hereditary neurodegenerative disorder caused by an autosomal dominant mutation.

Special Report: Clinical-stage biotech Neurizon Therapeutics has reached a milestone in development of its lead drug candidate NUZ-001 to treat Huntington’s disease.

Ingrezza is a selective vesicular monoamine transporter 2 (VMAT2) inhibitor approved for treating tardive dyskinesia and Huntington’s disease chorea in adults.